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Background: Osteoblasts and adipocytes share a common mesenchymal stem cell origin. Therefore, it has been
suggested that the accumulation of marrow adipocytes observed in bone loss is caused by a shift in the commitment
of mesenchymal stem cells from the osteogenic pathway to the adipogenic pathway. Supporting this hypothesis the
competition between adipogenic and osteogenic lineages was widely demonstrated on partially homogeneous cell
populations. However, some data from mouse models showed the existence of an independent relationship between
bone mineral content and bone marrow adiposity. Therefore, the combination of adipogenesis and osteogenesis in
primary culture would be helpful to determine if this competition would be observed on a whole bone marrow
stromal cell population in a culture medium allowing both lineages.
In this aim, mouse bone marrow stromal cells were cultured in a standard osteogenic medium added with different
concentrations of Dexamethasone, known to be an important regulator of mesenchymal progenitor cell differentiation.
Results: Gene expression of osteoblast and adipocyte markers, biochemical and physical analyses demonstrated
the presence of both cell types when Dexamethasone was used at 100 nM. Overall, our data showed that in
this co-differentiation medium both differentiation lineages were enhanced compared to classical adipogenic
or osteogenic culture medium. This suggests that in this model, adipocyte phenotype does not seem to
increase at the expense of the osteoblast lineage.
Conclusion: This model appears to be a promising tool to study osteoblast and adipocyte differentiation
capabilities and the interactions between these two processes.
Keywords: Bone marrow stromal cells, Cell differentiation, Dexamethasone, Co-differentiation medium,
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In bone diseases such as osteoporosis, it has been ob-
served an increase in the content of bone marrow adipo-
cytes at the expense of bone volume [1-3]. Two main
explanations were proposed. On the one hand, adipo-
cytes could express antiosteoblastic factors [4,5]. On the
other hand, because the both cell types share a common* Correspondence: christophe.chauveau@univ-littoral.fr
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unless otherwise stated.mesenchymal stem cell (MSC) progenitor [6-8], the in-
volvement of a competition between these two differenti-
ation pathways in the decrease of osteoblastic cell population
described in osteoporotic bone specimen is often evoked.
Nevertheless, some data, like independent alterations of
bone mineral content and bone marrow adiposity in some
mouse models [9], led to discuss more these hypotheses.
Indeed, several key questions remain to be answered. First,
antiosteoblastic factors from adipocytes remain to be iden-
tified. Second, the mechanism responsible for cell orienta-
tion to adipogenic or osteogenic lineage in the bonehis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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tive relationship between these two pathways in vivo is
still discussed particularly because of the existence of in-
dependent pre-osteoblastic and pre-adipocytic cell popu-
lations in the bone marrow [11].
Therefore, the combination of adipogenesis and osteo-
genesis in primary culture would be helpful not only to
identify modulators of the osteoblast/adipocyte balance
or to evaluate cell differentiation capacities, but also to
determine if the antagonism between adipocytes and os-
teoblasts, often described on a selected cell population,
would be observed in a more heterogeneous population
of bone marrow stromal cells (BMSCs).
Among molecules used in culture protocols to induce
cell differentiation, Dexamethasone (Dex), a synthetic
glucocorticoid, is known to be an important regulator of
mesenchymal progenitor cell commitment to osteoblast,
adipocyte and chondrocyte lineages. Indeed, it has been
demonstrated, in many studies, that Dex regulates the
osteogenesis of human MSCs and mineralization in vitro
[12-17]. It is also demonstrated that Dex has a pro-
osteogenic effect on mouse MSCs [18].
The involvement of Dex in the regulation of human
adipogenesis was described in many works [19,20]. It
has been shown that in human MSCs, continuous Dex
treatment augmented adipocyte differentiation in adipo-
genic medium, and osteoblast differentiation in osteogenic
medium [21]. Dex is also used for adipocyte differentiation
of mouse BMSCs [22]. In addition, Grigoriadis et al. [23]
showed on culture of clonal cell populations from rat
calvaria that Dex added to osteogenic medium induced
adipocytic differentiation while allowing osteoblastic
phenotype. Thus, we wondered whether Dex might be
used to allow both osteogenesis and adipogenesis in mur-
ine BMSCs. Therefore, in the present study, we investi-
gated the effect of different concentrations of Dex added
to osteogenic medium on adipocytic and osteoblastic
differentiation of mouse BMSCs. We showed that in this
medium only Dex at 100 nM induced adipocyte pheno-
type and increased osteoblast phenotype.
Results
Addition of Dex at 100 nM in osteogenic medium
strongly induced adipogenesis
To investigate the effect of Dex on differentiation, BMSCs
were cultured for 14 days in osteogenic medium sup-
plemented or not with different amounts of Dex ranging
from 50 nM to 150 nM. Oil red O staining revealed the
gradually appearance of lipid droplets in media supple-
mented with 75 and 100 nM (Figure 1A) while higher
doses in osteogenic medium (125 and 150 nM) seemed to
decrease the total number of cells during the culture ac-
cording to microscopic observations. Optical density of
the extracted oil red O revealed that the presence of Dexat 100 nM in osteogenic medium induced a higher lipid
accumulation than 100 nM and even 500 nM of Dex in
the adipogenic medium itself (Figure 1B).
Enhancement of adipocyte differentiation in this medium
was confirmed by the induction of mRNA of early and late
differentiation markers PPARgamma, glut4 (glucose trans-
porter type 4), AdipoQ (adiponectin) and leptin. As shown
in Figure 2, Dex added at 100 nM to the osteogenic
medium induced the highest adipocyte differentiation
because it enhanced the mRNA expression of all these
markers at the highest level. Surprisingly, leptin expression
was strongly increased only by Dex 100 nM in osteogenic
medium when compared with all other media. Even stand-
ard adipogenic medium with Dex 500 nM did not induce
an increase in leptin expression. This was not due to the
high concentration of Dex because also in a modified adi-
pogenic medium with only 100 nM of Dex, no increase in
leptin expression was observed (Figure 2). This suggests a
more complicated regulation of leptin expression in this
model.
To verify that adipocyte marker expression in osteogenic
medium supplemented with Dex 100 nM was not only
due to enhancement of some gene promoters by Dex, cells
were cultured in osteogenic medium for 14 days and 100
nM of Dex were added only for the last 2 days. This
addition of Dex did not modify the mRNA expression of
adipocyte markers when compared to standard osteogenic
medium (Figure 3), confirming the full commitment
of cells to the adipocyte differentiation pathway in O
100 medium.
Addition of Dex at 100 nM in osteogenic medium also
potentiated osteogenesis
The impact of Dex on osteoblast differentiation was also
determined. Alizarin red staining showed that BMSCs
mineralized in osteogenic medium when Dex was added
at concentrations ranging from 0 to 125 nM (Figure 4A).
Interestingly, our results demonstrated that the cal-
cium to protein ratio was higher in osteogenic medium
added with Dex 100 nM than in usual osteogenic medium
(Figure 4B).
Furthermore, quantitative RT-PCR results demonstrated
that when compared to usual osteogenic medium, only
100 nM of Dex in osteogenic medium induced an up-
regulation of osteoblast marker mRNA expressions (runx2,
osteocalcin (OC) and osterix (OSX)) but without any ef-
fect on the expression of the alkaline phosphatase (ALP)
(Figure 4C). We concluded that Dex added at 100 nM in-
duced the strongest osteoblast differentiation. Thus, we
selected this concentration for the further experiments
performed in co-differentiation medium.
Likewise the mRNA expression of adipocyte markers,
addition of Dex 100 nM for the last 2 days of the 2 week
culture in osteogenic medium did not modify the mRNA
Figure 1 (See legend on next page.)
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Figure 1 Dex addition in standard osteogenic medium induces adipocyte differentiation. Confluent BMSCs were cultured for 14 days in
growth medium (G 0), in growth medium added with Dex 100 nM (G 100), in adipogenic medium containing Dex 100 nM (A 100) or 500 nM (A
500), or cultured in osteogenic medium supplemented with 0 to 150 nM of Dex (O 0 to O 150). (A) The effect of Dex on adipocyte differentiation
was determined by oil red O staining. Representative images from four independent experiments are presented here. (B) Relative quantification
of lipid droplet formation was measured at 500 nm after oil red O staining and compared to adipogenic medium results. Representative data
from four independent experiments are shown as means +/− S.E.M. #p < 0.05 vs. A 500 medium.
Ghali et al. BMC Cell Biology  (2015) 16:9 Page 4 of 15expression of osteoblast markers (Figure 5). This could
indicate that the enhancement of osteoblast markers in
co-differentiation medium when compared to osteogenic
medium was not only due to a direct effect of Dex on
some gene promoters.
To determine if the increased levels of differentiation
markers were due to Dex effects on cell proliferation,
the relative quantification of mRNA cyclins (D1, E1 and
B1) was performed by quantitative RT-PCR after 3/7/10/
14 days of culture in growth medium (G0), adipogenic
medium with 500 nM of Dex (A 500), osteogenic medium
(O 0) and co-differentiation medium (O 100). Dex addition
did not alter the mRNA level of these cyclins (Figure 6A).
This suggested that Dex does not have any effect on cell
proliferation in our model. To strengthen this hypoth-
esis, we performed western blot analysis of Cyclin D1
(Figure 6B). These further experiments showed no ob-
vious differences at the protein level. Altogether, these
data led us to suppose that in our model, Dex acts by in-
ducing higher differentiation levels in the two lineages.
Characterization of mineralization nodules and lipid
accumulation by Raman microspectroscopy in the
co-differentiation medium
To characterize the nodules observed in the co-differentiation
medium and to confirm lipid accumulation in functional
adipocytes, we used the Raman microspectroscopy. In this
aim, we determined reference Raman spectra of cells dif-
ferentiated in adipogenic and osteogenic media respect-
ively. Indeed, the adipocyte phenotype of cells cultured in
adipogenic medium for 14 days was observed by optical
image which demonstrated presence of lipid droplets
(Figure 7A). The reference Raman spectra of these cells
with lipid droplets showed the presence of characteristic
bands of adipocytes as those described in the study of
Downes et al. [24]. These bands were found at 972, 1065,
1080, 1265, 1303, 1441, 1658 and 1744 cm−1 (Figure 7F).
They were not detected in undifferentiated cells (cells
grown in growth medium) and cell support (dish without
cells) (Figures 7C, H and K).
Osteoblast phenotype of cells cultured in osteogenic
medium for 14 days was determined by presence of
nodules (Figure 7B). Raman study of these nodules
showed spectra characteristic of apatitic calcium phosphate
as those found in previous studies [24,25], with bandsobserved at 426, 580 and 960 cm−1 (Figure 7G). They were
not detected in undifferentiated cells and cell support. The
assignment of all bands is specified in Table 1.
Optical images of cells cultured in co-differentiation
medium for 14 days showed the presence of lipid droplets
(Figure 7D) and nodules (Figure 7E) as those observed in
adipogenic and osteogenic media respectively. Interest-
ingly, the Raman analysis confirmed the accumulation of
lipids in adipocytes (Figure 7I) and the presence of apatitic
calcium phosphate (Figure 7J) in the co-differentiation
medium.
Relative localization of adipocytes and mineralized matrix
Cultures stained by calcein blue were observed under
white light (left panel) and UV light (right panel) to
localize adipocyte cells and mineralized matrix respect-
ively (Figure 8). In co-differentiation medium, adipocytes
were often observed very close to mineralized matrix
(Figure 8A). Calcein blue staining of mineralization appeared
less intense with usual osteogenic medium (Figure 8B).
This confirmed results from calcium/protein assays and
real time PCR experiments with osteoblastic markers. The
very low fluorescent signal observed on cells differentiated
in adipogenic medium confirmed the specificity of the
fluorescence.
Discussion
Mouse mesenchymal stem cell osteogenesis and adipogen-
esis are widely studied separately. The mechanisms and
factors driving cells preferentially to one of these differen-
tiation pathways are still discussed or to be identified. Be-
cause these two phenomena co-exist in the bone marrow,
we attempted to reproduce both of them in a single cul-
ture condition, for further studies on their interactions.
Dex was chosen as a key factor because of its effects
on osteoblastic and adipocytic differentiation capabilities
[12-23,26,27]. Interestingly, Dex effects were shown to be
dependent on cell differentiation stage. Indeed, in cells
committed to the osteogenic lineage, such as MC3T3-E1
and ROS 17/2.8 cells, Dex stimulated osteogenesis [28,29].
The high time dependency of Dex effects on mineralization
of human preosteoblast (SV-HFO) cultures was also dem-
onstrated [27]. Conversely, in non-committed cells, such as
C26 cells (clonal rat mesenchymal progenitor cell line),
Dex had a stimulatory action on adipogenesis [30]. In
Figure 2 (See legend on next page.)
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Figure 2 Dex addition in standard osteogenic medium induces adipocyte marker expression. Relative levels of mRNA adipocyte markers
(PPARgamma, glut4 (glucose transporter type 4), adiponectin (AdipoQ) and leptin) were determined on BMSCs cultured for 14 days in growth
medium (G 0), in growth medium added with Dex 100 nM (G 100), in adipogenic medium containing Dex 100 nM (A 100) or 500 nM (A 500),
or cultured in osteogenic medium (O 0) or osteogenic medium supplemented with 75 to 150 nM of Dex (O 75 to O 150). Levels of adipocyte
marker mRNAs were reported to the mean of mRNA level of two housekeeping genes Gapdh2, and 18S and expressed in percent of cells
cultured in growth medium. Representative data from four independent experiments depicted as means +/− S.E.M. are shown. #p < 0.05 vs.
A 500 medium.
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were widely dependent on its concentration. Particularly,
the number of adipocytic cells derived from mouse
BMSCs was higher with 10−6 M of Dex than with 10−9 M
[31]. Thus, to create an environment in which both osteo-
genesis and adipogenesis occur, we induced osteogenesis
by using a standard osteogenic medium, in which different
doses of Dex were added to also induce adipogenesis.
BMSC population was chosen because it contains non-
differentiated cells and cells partly committed to osteo-
blast or adipocyte lineages, as shown by the low levels
of late differentiation markers of adipocyte (leptin) and
osteoblast (osteocalcin) in cells cultured in growth medium.
Our results demonstrated that Dex at 100 nM induced adi-
pogenesis despite the presence of standard osteogenic fac-
tors. The emergence of adipocyte-like cells containing
lipid droplets was accompanied by a rise in mRNA level
of early as well as late adipocyte markers (PPARgamma,
glut4, adiponectin and leptin). The true adipocyte com-
mitment of these cells was supported by the absence of
enhancement of adipocyte markers when Dex was added
in the osteogenic medium for the last 2 days only.
Interestingly, Dex addition in osteogenic medium for
14 days also strongly increased the mineralization and
the mRNA level of osteoblast markers (runx2, osterix and
osteocalcin) when compared to cells differentiated in
osteogenic medium without Dex. We checked that levels
of mRNA cyclins (D1, E1 and B1) were not modified by
Dex addition (Figure 6A). To strengthen the hypothesis
that in our model Dex does not act through effects on cell
proliferation, we performed western blot analysis of cyclin
D1 which regulates the transition from G0 to G1 phases
of cell cycle. Indeed, the results of these experiments
suggested that there is no difference in cell proliferation
level independently of medium and culture duration. This
could be related to the cell culture confluence required in
this protocol before inducing cell differentiation. More-
over, as for the adipocyte markers, we verified that this
increase was not due to the enhancement of some
osteoblast gene promoters by Dex. Our experiments showed
that Dex added from day 12 to day 14 of osteoblast differ-
entiation did not modify osteoblast marker mRNA levels.
These results suggest that the higher levels of osteoblast
markers were due to a true increase in osteoblast activityby Dex. Even though, it could also be supposed that these
genes were no more sensitive to Dex at late days of osteo-
blastic differentiation. Taken together, all these results
show that in our study, Dex strongly supported both dif-
ferentiation pathways in the same culture medium.
Despite recent works showing that Dex treatment en-
hanced the alkaline phosphatase (ALP) mRNA level or
activity of C3H10T1/2 cells [32] and rat mesenchymal
cells [33,34], we did not find any difference in ALP
mRNA level between osteogenic medium with Dex and
osteogenic medium without Dex. This result could be ex-
plained by the fact that ALP is already strongly expressed
in the standard osteogenic medium and thus could not be
further enhanced by Dex addition. Indeed, we determined
ALP mRNA levels more than 5 folds higher in co-
differentiation medium than in growth medium, while in
very similar osteogenic experiments only a 2 folds increase
was shown [35].
In order to characterize the mineralization nodules
found in the co-differentiation medium and to confirm
lipid accumulation in the adipocytes, we used an original
and complementary approach, “the Raman microspectro-
scopy” because it is a non-destructive method. Recently,
its efficiency to characterize mineral content and to study
MSC differentiation was shown [24,25]. In our study, Ra-
man spectra with bands characteristic of apatitic cal-
cium phosphate and of lipid accumulation were obtained
in osteogenic and adipogenic cultures, respectively, and in
the co-differentiation medium cultures. These Raman
data further support the notion that in co-differentiation
medium both adipocytes and osteoblasts are formed.
Our experiments with staining of mineralized matrix
showed that in co-differentiation medium, adipocytes were
often observed at proximity of this matrix. This observa-
tion led us to suppose that adipocytes and osteoblasts were
able to develop in a close proximity. However, further in-
vestigations will be needed to determine more precisely
the relative localization of adipocytes and mineralized
nodules in this medium. Moreover, it would be useful to
study this topology after several culture durations to es-
tablish if adipocytes were differentiated after or before
mineralization. To hypothesize on the factors allowing
both enhancements in this model, it is to note that
whole bone marrow adherent cells were used. These cell
Figure 3 Dex addition in standard osteogenic medium for the
last 2 days has no effect on adipocyte differentiation. Relative
levels of mRNA adipocyte markers (PPARgamma, glut4 (glucose
transporter type 4), adiponectin (AdipoQ) and leptin) were
determined on BMSCs cultured for 14 days in growth medium
(G 0), in adipogenic medium containing Dex 500 nM (A 500), or
cultured in osteogenic medium (O 0) or osteogenic medium
supplemented with 100 nM of Dex (O 100) for 14 days or for
the last 2 days (O 100(2d)). Levels of adipocyte marker mRNAs
were reported to the mean of mRNA level of two housekeeping genes
Gapdh2, and 18S and expressed in percent of cells cultured in growth
medium. Representative data from four independent experiments
depicted as means +/− S.E.M. are shown. #p < 0.05 vs. O 0 medium.
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adipocytic cells as demonstrated by Post et al. [11], and by
expression of adipocyte and osteoblast marker in growth
medium (Figure 2). Interestingly, it was previously shown
that Dex increased the adipocytic differentiation in adipo-
genic medium and osteoblastic differentiation in osteo-
genic medium [21], and that Dex can enhance expression
of osteocalcin and aP2 (the fatty acid binding protein) in
cultured rat BMSCs [36]. Taken together, these data lead
to suppose that Dex potentiates the differentiation of cells
already committed to a differentiation pathway.
Numerous in vitro studies described the balance be-
tween adipogenesis and osteogenesis of human, rat or
mouse cells. Some of these studies showed that adipogenic
factor addition in the osteogenic medium induced a de-
crease in osteoblast markers or functions. Other studies
demonstrated that osteogenic factor addition induced a
decrease in adipocyte markers or functions. From these
data, authors concluded to a probable direct competition
between these two differentiation pathways. Moreover,
most of these studies were not done on the whole adher-
ent cell population of bone marrow, but on mesenchymal
progenitor or pluripotential cell lines. Then, another ex-
planation could be that in a selected cell population a
strong induction of one pathway compromises the initial
one. In the present study, adipocyte lineage does not seem
to increase at the expense of the osteoblast lineage, it can
be hypothesized that adipocytes are derived from cells that
would not be driven to the osteoblast lineage, even in pure
osteogenic medium. Therefore, in the bone marrow these
cells could be mesenchymal cells more or less committed
in a non-osteoblastic differentiation pathway. Further in-
vestigations are needed to confirm this hypothesis and to
characterize the underlying mechanisms. Despite we have
obtained the differentiation of adipocytes and osteoblasts,
our model represents some limitations because BMSC
cultures do not reproduce the whole niche of bone mar-
row stroma, niche that remains to be determined.
Finally, the highest values of parameters of osteoblast
and adipocyte differentiation were obtained for the same
concentration of Dex. This suggests a positive link between
Figure 4 Dex addition in standard osteogenic medium potentiates osteoblast differentiation. Osteoblast differentiation was tested on
BMSCs cultured for 14 days in growth medium (G 0), in adipogenic medium containing Dex 500 nM (A 500), or cultured in osteogenic medium
(O 0) or osteogenic medium supplemented with 75 to 150 nM of Dex (O 75 to O 150). (A) Mineralized nodules were highlighted by alizarin red
staining. Representative images from four independent experiments are presented here. (B) Mineralization was quantified by measuring the
calcium to protein ratio and compared to osteogenic medium results. Representative data from four independent experiments are shown as
means +/− S.E.M. (C) Relative levels of mRNA osteoblast markers (Runx2, OSX (osterix), ALP (alkaline phosphatase), OC (osteocalcin)) were
determined. Results were reported to expression of the mean of Gapdh2 and 18S and expressed in percent of cells cultured in growth medium.
Representative data from four independent experiments depicted as means +/− S.E.M. are shown. #p < 0.05 vs. O 0 medium.
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scribed that Dex enhances leptin release from human
adipose tissues [20,37,38] and that leptin has a direct pro-
osteogenic effect [20,39]. Our study showed that leptin ex-
pression stayed at the growth medium level when cells
were cultured in adipogenic medium with 100 or 500 nMof Dex, but it increased in the co-differentiation medium
(Figure 2). First, this led us to suppose the involvement of
the direct pro-osteogenic effect of leptin released from ad-
ipocytes, added to direct effects of Dex. Second, these re-
sults suggest that adipocytes induced in co-differentiation
medium could be different from those induced in
Figure 5 Dex addition in standard osteogenic medium for the
last 2 days has no effect on osteoblast differentiation. Relative
levels of mRNA osteoblast markers (Runx2, OSX (osterix), ALP
(alkaline phosphatase), OC (osteocalcin)) were determined on
BMSCs cultured for 14 days in growth medium (G 0), in adipogenic
medium containing Dex 500 nM (A 500), or cultured in osteogenic
medium (O 0) or osteogenic medium supplemented with 100 nM
of Dex (O 100) for 14 days or for the last 2 days (O 100(2d)). Results
were reported to expression of the mean of Gapdh2 and 18S
and expressed in percent of cells cultured in growth medium.
Representative data from four independent experiments depicted
as means +/− S.E.M. are shown. #p < 0.05 vs. O 0 medium.
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needed to characterize in greater detail these adipocytes.
Conclusion
In summary this study demonstrated that the classical
osteogenic medium added with 100 nM of Dex supports
adipocyte and osteoblast differentiation of mouse BMSCs.
The presence of both cell types was confirmed by several
approaches. It was also shown that both differentiation
lineages are enhanced in this medium when compared to
classical adipogenic or osteogenic culture medium.
Moreover, this co-differentiation medium offers the
opportunity to study BMSC differentiation capacities in
an environment allowing both lineages and to study
their interaction in great detail. This medium could also
allow identifying new modulators of the osteoblast/adi-
pocytes balance.
Methods
Primary bone marrow cell cultures
Female C57BL6 mice, 7 weeks of age, were purchased
from Charles River (St Germain sur l’Abresle, France)
and were acclimatized for 1 week under standard labora-
tory conditions (temperature 23 ± 1°C, humidity 50 ± 5%,
water and standard food ad libitum). Immediately after
sacrifice, femurs and tibias were removed and cleaned of
connective tissue, the ends were cut, and the marrow was
flushed with growth medium containing alpha Minimum
Essential Medium (α-MEM) (PAN Biotech, Dutsher, Brumath,
France) supplemented with 15% fetal calf serum (FCS)
(PAN Biotech), 2 mM of glutamine (PAN Biotech), 50 IU/
ml of penicillin (PAN Biotech), and 50 μg/ml of strepto-
mycin (PAN Biotech). Single-cell suspensions were pre-
pared in growth medium by passing the cells several times
through graded needles. Cell density was determined
using a Malassez counting chamber. For all experiments,
cells were plated at a density of 2 × 106 cells/cm2 and in-
cubated at 37°C in 5% CO2. After 24 hours, non-adherent
cells were removed and the medium was changed every
3 days until cell confluence. Mouse care and treatment
were conducted in accordance with institutional guidelines
in compliance with national law and policy. This study
Figure 6 Dex addition in standard osteogenic medium did not affect cell proliferation. (A) Dex effect on cell growth was determined by
measuring the mRNA expression of 3 cyclins (D1, E1 and B1) on BMSCs cultured for up to 14 days in growth medium (G 0), in adipogenic medium
containing Dex 500 nM (A 500), or cultured in osteogenic medium (O 0) or osteogenic medium supplemented with 100 nM of Dex (O 100). Results
were reported to expression of the mean of Gapdh2 and 18S and expressed in percent of cells cultured in growth medium. (B) Dex effect on cell
growth was assessed by performing western blot analysis of cyclin D1 in the same conditions as in (A).
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Experiments of Nord – Pas de Calais, France (Permit
number: CEEA #022012).
Osteogenic, adipogenic and co-differentiation media
Primary bone marrow-derived cells were induced to osteo-
genesis in the standard osteogenic medium composed by
α-MEM 10% FCS supplemented with 50 μg/ml ascorbic
acid (Sigma-Aldrich Corporation, St Quentin Fallavier,
France) and 10 mM β-glycerophosphate (Sigma-Aldrichcorporation) for up to 14 days and the medium was chan-
ged every 2 or 3 days.
Adipogenesis was induced in the standard adipogenic
medium containing Dulbecco’s Modified Eagle Medium
(DMEM) (PAN Biotech) 10% FCS supplemented with
10 μg/ml insulin/0,1 or 0,5 μM dexamethasone (depending
on the experiment)/100 μM indomethacin/500 μM 3-
isobutyl-1-methylxanthine (Sigma-Aldrich Corporation)
for 4 days and then maintained in 10 μg/ml insulin/0,1 or
0,5 μM dexamethasone/5 μM pioglitazone (Sigma-Aldrich
Figure 7 Characterization of mineralization nodules and lipid accumulation by Raman microspectroscopy in the co-differentiation
medium. BMSCs cultured for 14 days in osteogenic, adipogenic (with Dex 500 nM) or co-differentiation media (100 nM of Dex added to osteogenic
medium) were analyzed by Raman microspectroscopy. Optical images representative of three independent experiments performed in triplicate are
shown. (A) Lipid accumulation of adipocytes in the adipogenic medium. (B) Mineralized nodules of apatitic calcium phosphate named here bioapatite
(Bio-Ap) of cells cultured in the osteogenic medium. (C) Undifferentiated cells in the growth medium. (D) Lipid accumulation of adipocytes of cells
cultured in the co-differentiation medium. (E) Mineralized nodules of Bio-Ap of cells cultured in the co-differentiation medium. (F) Reference Raman
spectra of lipid accumulation of adipocytes in the adipogenic medium; (G) Reference Raman spectra of mineralized nodules of Bio-Ap in the
osteogenic medium; (H) Reference Raman spectra of undifferentiated cell in the growth medium; (I) Raman spectra of lipid accumulation
of adipocytes in the co-differentiation medium; (J) Raman spectra of mineralized nodules of Bio-Ap of cells cultured in the co-differentiation medium;
(K) Reference Raman spectra of cell support. The position of the Raman spectrum is indicated by white arrow heads; a.u. = arbitrary units.
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every 2 or 3 days.
In order to obtain both adipocytes and osteoblasts in
the same differentiation medium, cells were cultured in
the standard osteogenic medium supplemented with dif-
ferent concentrations of Dex ranging from 50 nM to 150
nM. For these experiments, co-differentiation medium re-
ferred to osteogenic medium added with 100 nM of Dex.
Oil red O staining and relative quantification
Cells were fixed in 2% paraformaldehyde for 15 min,
washed with water, incubated with 60% isopropanol for5 min and stained with newly filtered oil red O solution
for 10 min at room temperature. To quantify staining, oil
red O was extracted from the cells with isopropanol and
absorbance of the solution was measured at a wavelength
of 500 nm to determine the relative amount of dye.
Mineralization staining
Mineralization staining was studied by two tests: alizarin
red and calcein blue. For alizarin red, media were dis-
carded and cells were fixed with 4% paraformaldehyde and
stained with 2% alizarin red at pH 4.2. After 15 min of in-
cubation at 37°C, cells were thoroughly washed with water.
Table 1 Raman bands observed in the osteogenic,
adipogenic and co-differentiation media
Osteogenic
medium
Adipogenic
medium
Co-differentiation
medium
Assignments
426 426 ν2 PO4
580 580 ν4 PO4
960 960 ν1 PO4
972 972 δ (=C-H) out-of-plane
1002 1002 Phenylalanine/HPO4
1065 1065 ν(C-C)
1080 1080 ν(C-C)
1265 1265 δ (=C-H) lipids
1303 1303 δ(CH2) twisting lipids
1441 1441 1441 δ(CH2) scissor lipids/
proteins
1658 1658 1658 ν(C = C) lipids/proteins
1744 1744 ν(C = O) in CH2-COOR
Assignments are based on studies from Downes et al. [24].
Figure 8 Relative localization of adipocytes and mineralized matrix. B
(B) or adipogenic (C) medium and treated with 30 μM of calcein blue. Cell
In left and right panels of (A), the position of some adipocytes was indicat
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tiating cells were treated with 30 μM of solution and the
medium was changed every 3 days. Prior to microscope
examination, cultures were washed with fresh medium
and were fixed with 4% paraformaldehyde. Fluorescence
was observed by using DAPI filter.
Quantification of mineralization
Cells cultured for 14 days were harvested in a solution
of PBS 1X (Phosphate Buffered Saline, PAN Biotech)/
Triton 0.2%/HCl 6 M and disrupted by sonication. 5 μl
of HCl 6 M was added to 95 μl of each sample and incu-
bated overnight at 4°C. After centrifugation at 1500 × g
for 5 min, the protein content was determined using the
DC protein assay kit BioRad. The mineralization content
was quantified as previously described in the work of
Bruedigam et al. [40]. The results are shown as mM
Ca2+/mg protein.
Western blot analysis
Western blot analysis was performed as described previ-
ously [41]. For this study, rabbit polyclonal antibody
(Cyclin D1) and mouse monoclonal antibody (ß-Actin)MSCs were cultured for 14 days in co-differentiation (A), osteogenic
s were observed under white light (left) and under UV light (right).
ed by the arrow heads. Fluorescence refers to mineralized matrix.
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USA).RNA extraction
Total RNA was extracted from cultures with Extract-all
(Eurobio, Les Ulis, France) according to the manufacturer’s
protocol. Total RNA was quantified using the NanoDrop
2000 spectrophotometer (Thermo Scientific, Labteck,
Palaiseau, France), and the integrity of RNA was con-
trolled by the 28S:18S mRNA ratio after agarose gel
electrophoresis. Contaminating DNA was removed from
RNA samples by a 30 minute digestion at 37°C with
DNase I (Roche Applied Science, Meylan, France).Reverse transcription and Real-time PCR
Reverse transcription and real-time PCR were performed as
described previously in the work of Ghali et al. [41]. The se-
quences of the primers (TibMolBiol, Berlin, Germany) used
for each of the analyzed genes are shown in the Table 2.Table 2 Primers sequences and conditions of PCR
Gene Primer sequences Annea
Runx2 F: GCCGGGAATGATGAGAACTA 62°C
R: GGACCGTCCACTGTCACTTT
OC F: AAGCAGGAGGGCAATAAGGT 60°C
R: CGTTTGTAGGCGGTCTTCA
OSX F: CTAGTTCCTATGCTCCGACC 54°C
R: TCATCACATCATCATCGTG
ALP F:CAAAGGCTTCTTCTTGCTGGT 60°C
R: AAGGGCTTCTTGTCCGTGTC
PPAR gamma −2 F: GGTGAAACTCTGGGAGATTCT 55°C
R: CAACCATTGGGTCAGCTCTTG
Leptin F: CTCATGCCAGCACTCAAAAA 62°C
R: AGCACCACAAAACCTGATCC
Glut4 F: ACTCTTGCCACACAGGCTCT 62°C
R: AATGGAGACTGATGCGCTCT
Adiponectin F: CCCAGTCATGCCGAAGA 62°C
R: TACATTGGGAACAGTGACGC
GAPDH F: GGCATTGCTCTCAATGACAA 62°C
R: TGTGAGGGAGATGCTCAGTG
18S F: ATTCCGATAACGAACGAGAC 60°C
R: GCTTATGACCCGCACTTACT
Cyclin D1 F: CGCACTTTCTTTCCAGAGTCA 55°C
R: AAGGGCTTCAATCTGTTCCTG
Cyclin E1 F: TCAACGACACGGGTGAG 55°C
R: ATGTCGCACCACTGATAACCT
Cyclin B1 F: CGCTCAGGGTCACTAGG 54°C
R: CTTCGCTGACTTTATTACCAARaman microspectroscopy
Cells cultured in growth, adipogenic, osteogenic or co-
differentiation media were fixed in 4% paraformaldehyde.
After rinsing, the fixed plates were analyzed with Raman
microspectrometer LabRAM HR800 (Jobin-Yvon, France).
The instrument was equipped with a XYZ motorized
stage and a diode laser at 785 nm. The Raman spectrom-
eter was coupled with microscope (BX40, Olympus).
Raman acquisitions were done with an immersion object-
ive (Olympus LUMPLFL 100XW, numerical aperture = 1,
Japan). The water immersion objective focused the laser on
the cell within the micrometer scale. Spectral acquisition
was made in the 300–1700 cm−1 range and spectral reso-
lution was 4 cm−1. The Raman signal was collected by
a multichannel CCD detector (1024 × 256 pixels). The
acquisition time was set at 60s per spectrum. Raman
spectra were processed using Labspec software (HORIBA,
Jobin-Yvon, France). A Savitzky-Golay smoothing filter
and polynomial baseline correction were applied to all
Raman spectra.ling temperature Product length Genbank
200 bp NM_001146038.2
364 bp NM_007541.3
237 bp NM_130458.1
257 bp NM_007431.3
268 bp NM_011146.3
197 bp NM_008493.3
174 bp NM_009204.2
354 bp NM_009605.4
200 bp NM_008084.1
297 bp NR_003278.3
74 bp NM_007631.2
196 bp NM_007633.2
159 bp NM_172301.3
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nodules represented a 30 spectra of cells cultured in adipo-
genic medium and 30 spectra of cells cultured in osteo-
genic medium, respectively. To confirm the adipogenic
and osteogenic phenotypes, spectra were compared with
those described by Crane et al. [25] and Downes et al. [24].
The Raman spectra of undifferentiated cells (cells cul-
tured in growth medium) and cell support (dish without
cells) were also determined as negative controls.
To identify the adipocyte phenotype in the co-differentiation
medium, adipocytes were selected according to the pres-
ence of lipid droplets. On these cells, 30 spectra were
acquired and compared to reference Raman spectra of
adipocytes. The presence of mineralized nodules was
confirmed in this medium by acquiring 30 spectra on
supposed mineralized area. These spectra were compared
to reference Raman spectra from standard osteogenic
medium. The same protocol was applied for cells without
lipid droplets and without mineralized nodules. Obtained
spectra were close to those from cells cultured in growth
medium (undifferentiated cells). The Raman bands observed
in the osteogenic, the adipogenic and the co-differentiation
media and their assignments are summarized in the Table 1.
Statistical analysis
All experiments were done in triplicate and repeated
four times (with the exception of Raman analyses that
were repeated three times). Mean values and S.E.M.
(Standard Errors of the Mean) were calculated on the
four independent experiments. The Mann-Whitney’s test
for the statistical significance was performed by using
GraphPad Prism software. Differences with p <0.05 were
considered statistically significant.
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